Related Experiment Video
Updated: Jul 3, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Ethical dilemmas in device treatment for advanced heart failure
James N Kirkpatrick1, Savitri E Fedson, Ralph Verdino
1Department of Medicine, Cardiovascular Division and Bioethics Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Insights
Device therapy for heart failure offers benefits but raises ethical concerns regarding patient quality of life and societal costs. Improved end-of-life care planning and multidisciplinary approaches are crucial for optimal patient management.
Area of Science:
- Cardiology
- Medical Ethics
- Health Economics
Background:
- Device therapy is increasingly used for advanced heart failure.
- Ethical considerations surrounding device implantation and management are paramount.
Purpose of the Study:
- To review the ethical issues associated with the growing use of device therapy for heart failure.
- To examine the balance between benefits, harms, and costs of cardiac device interventions.
Main Methods:
- Literature review of recent guidelines, clinical trials, and commentaries.
- Analysis of studies addressing device deactivation and end-of-life care planning.
Main Results:
- Device therapy demonstrates benefits in advanced heart failure but carries risks of reduced quality of life and high societal costs.
- Low rates of advance care planning are reported for device management at the end of life.
- Specific ethical challenges arise concerning device deactivation.
Conclusions:
- Further research is essential to address the ethical complexities of cardiac device therapy.
- Enhanced end-of-life education and a stronger emphasis on advance directives are needed.
- A multidisciplinary approach is critical for optimizing care for heart failure patients undergoing device therapy.
Purpose Of The Review:
This review discusses the ethical issues raised by the increased use of devices to treat heart failure.
Recent Findings:
Recent guidelines and clinical trials describe the benefits of device therapy in advanced heart failure. Other studies and commentaries illustrate the potential for harm, both to the individual patient in the form of reduced quality of life and to society in the form of unbearable costs. Recent reports discuss the specific issues involved with deactivating different devices and document low rates of advanced care planning in relation to device management at the end of life.
Summary:
More research, increased end-of-life education, renewed emphasis on advance directives, and a true multidisciplinary approach are needed to provide optimal care for heart failure patients in relation to device therapy.
Related Concept Videos
Ethical Issues
Ethical Concerns in Healthcare:
Heart Failure VI: Adjunct Therapies
Ethical Dilemmas II
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...